The role of ET(B) receptors in normotensive and hypertensive rats as revealed by the non-peptide selective ET(B) receptor antagonist Ro 46-8443

被引:48
作者
Clozel, M
Breu, V
机构
[1] Pharma Division, Preclinical Research, c/o F. Hoffmann-La Roche Ltd., CH-4070 Basel
关键词
endothelin; ET(B) receptor; hypertensive rat; nitric oxide; endothelin receptor antagonist;
D O I
10.1016/0014-5793(96)00212-8
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We used Ro 46-8443, non-peptidic antagonist selective of endothelin ET(B) receptors, to study the role of ET(B) receptors in rat hypertension models. In normotensive rats, Ro 46-8443 decreased blood pressure, but in SHR and DOCA rats, it induced a presser effect, due to blockade of ET(B)-mediated release of nitric oxide since L-NAME prevented it. In rats rendered hypertensive by chronic L-NAME, Ro 46-8443 did not induce a presser but depressor effect. Thus, in DOCA rats and SHR, Ro 46-8443 reveals a predominant influence of endothelial 'vasorelaxant' ET(B) receptors, while in normotensive rats the prevailing role of ET(B) receptors seems to be in mediating a vasoconstrictor tone.
引用
收藏
页码:42 / 45
页数:4
相关论文
共 20 条
  • [1] ETB RECEPTORS ON AORTIC SMOOTH-MUSCLE CELLS OF SPONTANEOUSLY HYPERTENSIVE RATS
    BATRA, VK
    MCNEILJ, JR
    XU, YJ
    WILSON, TW
    GOPALAKRISHNAN, V
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY, 1993, 264 (02): : C479 - C484
  • [2] BRANDLI P, 1996, IN PRESS PAIN
  • [3] In vitro characterisation of Ro 46-8443, the first non-peptide antagonist selective for the endothelin ET(B) receptor
    Breu, V
    Clozel, M
    Burri, K
    Hirth, G
    Neidhart, W
    Ramuz, H
    [J]. FEBS LETTERS, 1996, 383 (1-2) : 37 - 41
  • [4] CLOZEL M, 1994, J PHARMACOL EXP THER, V270, P228
  • [5] PATHOPHYSIOLOGICAL ROLE OF ENDOTHELIN REVEALED BY THE 1ST ORALLY-ACTIVE ENDOTHELIN RECEPTOR ANTAGONIST
    CLOZEL, M
    BREU, V
    BURRI, K
    CASSAL, JM
    FISCHLI, W
    GRAY, GA
    HIRTH, G
    LOFFLER, BM
    MULLER, M
    NEIDHART, W
    RAMUZ, H
    [J]. NATURE, 1993, 365 (6448) : 759 - 761
  • [6] CLOZEL M, 1995, J CARDIOVASC PHARM, V26, pS262
  • [7] IN-VIVO PHARMACOLOGY OF RO 46-2005, THE 1ST SYNTHETIC NONPEPTIDE ENDOTHELIN RECEPTOR ANTAGONIST - IMPLICATIONS FOR ENDOTHELIN PHYSIOLOGY
    CLOZEL, M
    BREU, V
    GRAY, GA
    LOFFLER, BM
    [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1993, 22 : S377 - S379
  • [8] CHARACTERIZATION OF ENDOTHELIN RECEPTORS MEDIATING CONTRACTION OF RABBIT SAPHENOUS-VEIN
    GRAY, GA
    LOFFLER, BM
    CLOZEL, M
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY, 1994, 266 (03): : H959 - H966
  • [9] POTENTIATION BY ENDOTHELIN-1 OF CHOLINERGIC NERVE-MEDIATED CONTRACTIONS IN MOUSE TRACHEA VIA ACTIVATION OF ET(B) RECEPTORS
    HENRY, PJ
    GOLDIE, RG
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1995, 114 (03) : 563 - 569
  • [10] BIOCHEMICAL AND PHARMACOLOGICAL PROFILE OF A POTENT AND SELECTIVE ENDOTHELIN B-RECEPTOR ANTAGONIST, BQ-788
    ISHIKAWA, K
    IHARA, M
    NOGUCHI, K
    MASE, T
    MINO, N
    SAEKI, T
    FUKURODA, T
    FUKAMI, T
    OZAKI, S
    NAGASE, T
    NISHIKIBE, M
    YANO, M
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (11) : 4892 - 4896